HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Catafau, A. M. Articles by Carrió, I. Search for Related Content PubMed PubMed Citation Articles by Catafau, A. M. Articles by Carrió, I.

Regional Cerebral Blood Flow Changes in Chronic Alcoholic Patients Induced by Naltrexone Challenge During Detoxification

Nuclear Medicine Department and Addictive Behavior Unit, Hospital de Sant Pau, Barcelona
Departamento de Psiquiatría y Medicina Legal, Universitat Autónoma de Barcelona, Barcelona, Spain

Correspondence: For correspondence or reprints contact: Ana M. Catafau, MD, Servicio de Medicina Nuclear, Hospital de Sant Pau, Sant Antoni M. Claret, 167, 08025 Barcelona, Spain.

ABSTRACT

The recent introduction of the opioid antagonist naltrexone for alcohol-dependence therapy has been mainly based on behavioral animal models that provide evidence of the involvement of the endogenous opioid system in alcohol drinking and dependence. However, the neurophysiological mechanisms of the effect of naltrexone in alcoholic patients remain unknown. This study investigates the effects of a naltrexone challenge on regional cerebral blood flow (rCBF) in chronic alcoholic patients during detoxification. Methods: Sixteen alcoholic inpatients underwent two ^99mTc-hexamethyl propyleneamine oxime (HMPAO) brain SPECTs: a basal SPECT on day 10 of abstinence and a second SPECT on day 12 of abstinence after oral administration of 150 mg naltrexone. Region-to-cerebellar ratios were obtained for the orbitary frontal, prefrontal, lateral temporal and mesial temporal regions, basal ganglia and thalamus in each hemisphere. A percentage of rCBF change between both SPECTs was calculated for each region as 100 x (naltrexone – baseline)/baseline. Values from 13 brain SPECTs of age-matched normal volunteers including test-retest measurements were used for statistical comparison. Results: In baseline conditions, alcoholics showed lower rCBF than controls in left orbitofrontal cortex (84.0 ± 5.1 versus 89.8 ± 5.0, P < 0.01) and prefrontal cortex (left hemisphere: 87.4 ± 5.2 versus 96.2 ± 3.6, P < 0.001; right hemisphere: 87.0 ± 4.9 versus 95.8 ± 4.2, P < 0.001). After naltrexone, a significant rCBF decrease was found versus test-retest values in left basal ganglia (–3.3% ± 4.0% versus 1.5% ± 4.1%, P < 0.05), right basal ganglia (–4.2% ± 4.9% versus 0.6% ± 2.7%, P < 0.01) and left mesial temporal region (–4.5% ± 6.8% versus 2.2% ± 2.9%, P < 0.01). Conclusion: The rCBF decrease detected by SPECT after naltrexone challenge in structures rich in opioid receptors, such as the basal ganglia and the left mesial temporal region, may reflect a naltrexone-induced decreased metabolic activity in these areas. These results support the involvement of the opioid system in alcohol dependence. Furthermore, the localization of naltrexone-induced rCBF changes in mesial temporal structures and in basal ganglia supports the implication of emotional memory and obsessive-compulsive phenomena in craving.

Key Words: SPECT • regional cerebral blood flow • naltrexone • alcoholism

This article has been cited by other articles:

				G. Dom, B. Sabbe, W. Hulstijn, and W. van den Brink Substance use disorders and the orbitofrontal cortex: Systematic review of behavioural decision-making and neuroimaging studies The British Journal of Psychiatry, September 1, 2005; 187(3): 209 - 220. [Abstract] [Full Text] [PDF]

				A. DE SOUSA and A. DE SOUSA A ONE-YEAR PRAGMATIC TRIAL OF NALTREXONE VS DISULFIRAM IN THE TREATMENT OF ALCOHOL DEPENDENCE Alcohol Alcohol., November 1, 2004; 39(6): 528 - 531. [Abstract] [Full Text] [PDF]

				X. Setoain, S. Arroyo, F. Lomena, J. Pavia, D. Pareto, T. Boget, N. Bargallo, J. Rumia, D. Fuster, S. Fuertes, et al. Can the Wada test evaluate mesial temporal function?: A SPECT study Neurology, June 22, 2004; 62(12): 2241 - 2246. [Abstract] [Full Text] [PDF]

				R. Z. Goldstein and N. D. Volkow Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex Am J Psychiatry, October 1, 2002; 159(10): 1642 - 1652. [Abstract] [Full Text] [PDF]

				G. Rubio, M. A. Jimenez-Arriero, G. Ponce, and T. Palomo NALTREXONE VERSUS ACAMPROSATE: ONE YEAR FOLLOW-UP OF ALCOHOL DEPENDENCE TREATMENT Alcohol Alcohol., September 1, 2001; 36(5): 419 - 425. [Abstract] [Full Text] [PDF]

				A. M. Catafau Brain SPECT in Clinical Practice. Part I: Perfusion J. Nucl. Med., February 1, 2001; 42(2): 259 - 271. [Abstract] [Full Text]

				N. D. Volkow and J. S. Fowler Addiction, a Disease of Compulsion and Drive: Involvement of the Orbitofrontal Cortex Cereb Cortex, March 1, 2000; 10(3): 318 - 325. [Abstract] [Full Text] [PDF]